Google Übersetzer
Seres Therapeutics Inc
About
Seres Therapeutics Inc (NASDAQ:MCRB) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
Apr 9 2026
Seres Therapeutics to Present at CARB-X Investor Day
Mar 12 2026
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Mar 2 2026
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Feb 12 2026
Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases
Recent Videos
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO
Mar 03, 2026
02_12_26 Biotech Stock News. Daily Recap. #English #Shorts $XBI #trading #biotechnews #dailynews
Feb 12, 2026
Seres Therapeutics: Hold or Fold?! ⚠️ Gut Bacteria Stock
Feb 07, 2026
POTENTIAL UPSIDE : MCRB STOCK ANALYSIS | SERES THERAPEUTICS STOCK
Dec 23, 2025
Financials
Revenue
$789 K
Market Cap
$88.86 M
P/E Ratio
14.48
EPS
0.64
